Evidence map›Paper›PMID 40318017›Full record

ArticleActa obstetricia et gynecologica Scandinavica2025

The recurrence risk of gestational diabetes according to the number of abnormal values in the oral glucose tolerance test.

Jenni Pukkila, Marja Vääräsmäki, Sanna Eteläinen, Sanna Mustaniemi, Hilkka Nikkinen, Mika Gissler, Tuija Männistö, Hannele Laivuori, Eero Kajantie, Elina Keikkala and 1 more

Abstract read
In one paragraph

Article in Acta obstetricia et gynecologica Scandinavica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jenni PukkilaResearch Unit of Clinical Medicine, Department of Obstetrics and Gynecology, Medical Research Center, Oulu University Hospital, University of Oulu, Oulu, Finland.ORCID https://orcid.org/0000-0003-1761-7050
Marja VääräsmäkiResearch Unit of Clinical Medicine, Department of Obstetrics and Gynecology, Medical Research Center, Oulu University Hospital, University of Oulu, Oulu, Finland.
Sanna EteläinenResearch Unit of Clinical Medicine, Department of Obstetrics and Gynecology, Medical Research Center, Oulu University Hospital, University of Oulu, Oulu, Finland.
Sanna MustaniemiResearch Unit of Clinical Medicine, Department of Obstetrics and Gynecology, Medical Research Center, Oulu University Hospital, University of Oulu, Oulu, Finland.ORCID https://orcid.org/0000-0003-4483-830X
Hilkka NikkinenResearch Unit of Clinical Medicine, Department of Obstetrics and Gynecology, Medical Research Center, Oulu University Hospital, University of Oulu, Oulu, Finland.
Mika GisslerDatasets and Dataproducts Unit, Department of Data and Analytics, Finnish Institute for Health and Welfare, Helsinki, Finland.
Tuija MännistöDepartment of Clinical Chemistry, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
Hannele LaivuoriFaculty of Medicine and Health Technology, Center for Child, Adolescent and Maternal Health Research, Tampere University, Tampere, Finland.ORCID https://orcid.org/0000-0003-3212-7826
Eero KajantieResearch Unit of Clinical Medicine, Department of Obstetrics and Gynecology, Medical Research Center, Oulu University Hospital, University of Oulu, Oulu, Finland.
Elina KeikkalaResearch Unit of Clinical Medicine, Department of Obstetrics and Gynecology, Medical Research Center, Oulu University Hospital, University of Oulu, Oulu, Finland.
FinnGeDi Study Group

Funding

DiabetestutkimussäätiöEmil Aaltosen SäätiöHelsingin ja Uudenmaan SairaanhoitopiiriJuho Vainion SäätiöLastentautien TutkimussäätiöMedical Research Center OuluNovo Nordisk FondenOulun YliopistoOulun Yliopistollinen SairaalaResearch Council of FinlandSigne ja Ane Gyllenbergin SäätiöSigrid Juséliuksen SäätiöSuomen Lääketieteen SäätiöTerveyden ja hyvinvoinnin laitosWellcome Trust 220086Yrjö Jahnssonin Säätiö
6 · The paper itself

Abstract

introductionOral glucose tolerance test (OGTT) results may be used to estimate the risk of recurrent gestational diabetes mellitus (GDM) in a subsequent pregnancy in the different study settings. This study assesses the association between the number of abnormal glucose values in the OGTT in the first pregnancy and GDM recurrence in a subsequent pregnancy in a Nordic cohort. MATERIAL AND

methodsThis register-based cohort study included 1677 women who had their first singleton delivery in 2009, underwent a 75 g 2-h OGTT during the pregnancy, and gave birth at least once more within 10 years according to the Finnish Medical Birth Register. The cut-off values were as follows: ≥5.3 mmol/L at fasting, ≥10.0 mmol/L at 1 h, and ≥8.6 mmol/L at 2 h. The odds ratio (OR) for GDM recurrence in the second pregnancy was analyzed via multivariable logistic regression adjusted for other potential factors associated with recurrence risk.

resultsDuring the first pregnancy, GDM was diagnosed in 331 (24.5%) women based on one (n = 250) or two or three (n = 81) abnormal glucose values in the OGTT. The total recurrence rate for GDM in the subsequent pregnancy was 56.2%. The rate differed significantly between women with one (51.6%) and women with two or three (70.4%) abnormal values in first-pregnancy OGTT. Compared with those with normal OGTT results, the adjusted OR (aOR) for GDM in the subsequent pregnancy in women with one abnormal glucose value was 6.00 (95% CI, 4.34-8.30), while it was 13.37 (7.52-23.76) in women with two or three abnormal values. The odds for GDM recurrence among those with two or three abnormal glucose values was double compared to those with only one abnormal value (aOR 2.03, 1.12-3.68).

conclusionsPrimiparous women with one abnormal glucose value in the first OGTT have remarkable odds of GDM recurrence, with the odds doubling when there are two or three abnormal values during the first pregnancy. These findings can be used when planning effective counseling, prevention, and screening strategies for GDM in the subsequent pregnancy.

Indexed as

Blood GlucoseDiabetes, GestationalAdultCohort StudiesFemaleFinlandGlucose Tolerance TestHumansLogistic ModelsPregnancyRecurrenceRegistriesRisk FactorsBlood Glucosediabeteshigh‐risk pregnancypregnancywomen's health issues

Identifiers

PMID40318017
PMCPMC12283174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.